Literature DB >> 15763421

Ca2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives.

Tasmina A Goraya1, Dermot M F Cooper.   

Abstract

Ca2+-calmodulin-dependent phosphodiesterases (PDE1), like Ca2+-sensitive adenylyl cyclases (AC), are key enzymes that play a pivotal role in mediating the cross-talk between cAMP and Ca2+ signalling. Our understanding of how ACs respond to Ca2+ has advanced greatly, with significant breakthroughs at both the molecular and functional level. By contrast, little is known of the mechanisms that might underlie the regulation of PDE1 by Ca2+ in the intact cell. In living cells, Ca2+ signals are complex and diverse, exhibiting different spatial and temporal properties. The potential therefore exists for dynamic changes in the subcellular distribution and activation of PDE1 in relation to intracellular Ca2+ dynamics. PDE1s are a large family of multiply-spliced gene products. Therefore, it is possible that a cell-type specific response to elevation in [Ca2+]i can occur, depending on the isoform of PDE1 expressed. In this article, we summarize current knowledge on Ca2+ regulation of PDE1 in the intact cell and discuss approaches that might be undertaken to delineate the responses of this important group of enzymes to changes in [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763421     DOI: 10.1016/j.cellsig.2004.12.017

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  38 in total

Review 1.  Bursting and calcium oscillations in pancreatic beta-cells: specific pacemakers for specific mechanisms.

Authors:  L E Fridlyand; N Tamarina; L H Philipson
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-13       Impact factor: 4.310

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 3.  Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle.

Authors:  Vera V Koledova; Raouf A Khalil
Journal:  Circ Res       Date:  2006-05-26       Impact factor: 17.367

4.  The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.

Authors:  Hong Ye; Xiaofang Wang; Megan M Constans; Caroline R Sussman; Fouad T Chebib; María V Irazabal; William F Young; Peter C Harris; Lawrence S Kirschner; Vicente E Torres
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

Review 5.  The cyclic AMP pathway.

Authors:  Paolo Sassone-Corsi
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

6.  Temporally resolved cAMP monitoring in endothelial cells uncovers a thrombin-induced [cAMP] elevation mediated via the Ca²+-dependent production of prostacyclin.

Authors:  R C Werthmann; M J Lohse; M Bünemann
Journal:  J Physiol       Date:  2010-11-08       Impact factor: 5.182

7.  BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function.

Authors:  Wenkuan Xin; Ning Li; Vitor S Fernandes; Biao Chen; Eric S Rovner; Georgi V Petkov
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

8.  Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase.

Authors:  Qing Huai; Yingjie Sun; Huanchen Wang; Dwight Macdonald; Renée Aspiotis; Howard Robinson; Zheng Huang; Hengming Ke
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

9.  Store-operated cyclic AMP signalling mediated by STIM1.

Authors:  Konstantinos Lefkimmiatis; Meera Srikanthan; Isabella Maiellaro; Mary Pat Moyer; Silvana Curci; Aldebaran M Hofer
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

10.  Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Meera Sridharan; Shaquria Adderley; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.